Please assess the completion status of the following clinical trial:

Trial Title: Seton or Glue for Trans-sphincteric Anal Fistulas

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* medium or high trans-sphincteric fistulas of cryptoglandular origin, no previous treatments~Exclusion Criteria:~* Crohn's disease~* anal abscesses~* complex fistulas (horse-shoe type or multiple secondary tracts)~* immunosuppression~* diabetes,~* anal fissures~* pregnancy~* anti-coagulant treatments,~* any allergic reaction to the bioglue components.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- glue (Tissucol ) treatment (Type: EXPERIMENTAL): patients with transsphincteric anal fistulas of cryptoglandular origin never operated on before
- Seton treatment (Type: ACTIVE_COMPARATOR): patients with transsphincteric anal fistulas of cryptoglandular origin never operated on before

Based on this trial design, predict the completion outcome and termination type (if applicable).